BSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
NSE Live
Oct 10, 15:56Prev. Close
11.10
Open Price
11.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
207.59 (427)
Profit & Loss account of Vaishali Pharma (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
INCOME | ||||||
Revenue From Operations [Gross] | 58.41 | 72.46 | 65.33 | 61.68 | 66.71 | |
Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Revenue From Operations [Net] | 58.41 | 72.46 | 65.33 | 61.68 | 66.71 | |
Total Operating Revenues | 60.09 | 75.09 | 67.76 | 63.97 | 66.71 | |
Other Income | 2.17 | 1.98 | 1.66 | 0.93 | 3.18 | |
Total Revenue | 62.26 | 77.07 | 69.42 | 64.91 | 69.89 | |
EXPENSES | ||||||
Cost Of Materials Consumed | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Purchase Of Stock-In Trade | 50.99 | 67.78 | 60.61 | 53.94 | 62.07 | |
Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Changes In Inventories Of FG,WIP And Stock-In Trade | 0.10 | 0.89 | -0.71 | 2.21 | -0.04 | |
Employee Benefit Expenses | 1.93 | 2.13 | 2.04 | 1.59 | 1.56 | |
Finance Costs | 2.48 | 2.64 | 2.85 | 3.10 | 3.37 | |
Depreciation And Amortisation Expenses | 0.44 | 0.27 | 0.25 | 0.28 | 0.37 | |
Other Expenses | 6.24 | 2.25 | 3.03 | 2.77 | 2.57 | |
Total Expenses | 62.18 | 75.94 | 68.08 | 63.87 | 69.89 | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 0.08 | 1.13 | 1.35 | 1.03 | 0.00 | |
Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Profit/Loss Before Tax | 0.08 | 1.13 | 1.35 | 1.03 | 0.00 | |
Tax Expenses-Continued Operations | ||||||
Current Tax | 0.06 | 0.40 | 0.48 | 0.34 | 0.04 | |
Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Tax | -0.01 | -0.03 | -0.01 | -0.01 | -0.01 | |
Tax For Earlier Years | 0.00 | 0.05 | 0.08 | 0.00 | 0.00 | |
Total Tax Expenses | 0.05 | 0.42 | 0.55 | 0.32 | 0.03 | |
Profit/Loss After Tax And Before ExtraOrdinary Items | 0.03 | 0.71 | 0.80 | 0.71 | -0.03 | |
Profit/Loss From Continuing Operations | 0.03 | 0.71 | 0.80 | 0.71 | -0.03 | |
Profit/Loss For The Period | 0.03 | 0.71 | 0.80 | 0.71 | -0.03 | |
OTHER ADDITIONAL INFORMATION | ||||||
EARNINGS PER SHARE | ||||||
Basic EPS (Rs.) | 0.03 | 1.08 | 1.41 | 2.37 | -0.10 | |
Diluted EPS (Rs.) | 0.03 | 1.08 | 1.41 | 2.37 | -0.10 | |
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
STORES, SPARES AND LOOSE TOOLS | ||||||
Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
Equity Share Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Equity Dividend Rate (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
10.09.2025
Vaishali Pharma Standalone June 2025 Net Sales at Rs 23.75 crore, up 31.35% Y-o-Y
12.06.2025
Vaishali Pharma Standalone March 2025 Net Sales at Rs 32.25 crore, down 0.46% Y-o-Y
26.11.2024
Vaishali Pharma Standalone September 2024 Net Sales at Rs 20.79 crore, up 65.42% Y-o-Y
19.08.2024
Vaishali Pharma Standalone June 2024 Net Sales at Rs 18.08 crore, up 34.7% Y-o-Y
10.09.2025
Vaishali Pharma Standalone June 2025 Net Sales at Rs 23.75 crore, up 31.35% Y-o-Y
12.06.2025
Vaishali Pharma Standalone March 2025 Net Sales at Rs 32.25 crore, down 0.46% Y-o-Y
26.11.2024
Vaishali Pharma Standalone September 2024 Net Sales at Rs 20.79 crore, up 65.42% Y-o-Y
19.08.2024
Vaishali Pharma Standalone June 2024 Net Sales at Rs 18.08 crore, up 34.7% Y-o-Y